Anti-Müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Lindhardt Johansen, Marie ^a   Hagen, Casper P ^a   Johannsen, Trine Holm ^a   Main, Katharina M ^a   Picard, Jean Yves ^b   Jørgensen, Anne ^a   Rajpert De Meyts, Ewa ^a   Juul, Anders ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893856738     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/198698     Document Type: Review

References (106)

1. Jost A., Hormonal factors in the sex differentiation of the mammalian foetus. Philosophical transactions of the Royal Society of London. Series B 1970 259 828 119 130 2-s2.0-0014935137
2. Josso N., Racine C., Di Clemente N., Rodolfo Rey R. R., Xavier F., The role of anti-Müllerian hormone in gonadal development. Molecular and Cellular Endocrinology 1998 145 1-2 3 7 2-s2.0-0032566882 10.1016/S0303-7207(98) 00186-5 (Pubitemid 29003170)
3. Rey R. A., Grinspon R. P., Normal male sexual differentiation and aetiology of disorders of sex development. Best Practice and Research: Clinical Endocrinology and Metabolism 2011 25 2 221 238 2-s2.0-79952559094 10.1016/j.beem.2010.08.013
4. Lin Y.-H., Chiu W.-C., Wu C.-H., Tzeng C.-R., Hsu C.-S., Hsu M.-I., Anti-Müllerian hormone and polycystic ovary syndrome. Fertility and Sterility 2011 96 1 230 235 2-s2.0-79959914104 10.1016/j.fertnstert.2011.04.003
5. Jamieson S., Fuller P. J., Molecular pathogenesis of granulosa cell tumors of the ovary. Endocrine Reviews 2012 33 1 109 144 2-s2.0-84857837160 10.1210/er.2011-0014
6. Young J., Rey R., Couzinet B., Chanson P., Josso N., Schaison G., Anti-Müllerian hormone in patients with hypogonadotropic hypogonadism. The Journal of Clinical Endocrinology & Metabolism 1999 84 8 2696 2699 2-s2.0-0033237707 (Pubitemid 30641995)
7. Cate R. L., Mattaliano R. J., Hession C., Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 1986 45 5 685 698 2-s2.0-0022499726 (Pubitemid 16063132)
8. Cohen-Haguenauer O., Picard J. Y., Mattei M.-G., Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19. Cytogenetics and Cell Genetics 1987 44 1 2 6 2-s2.0-0023154197 (Pubitemid 17037164)
9. Imbeaud S., Faure E., Lamarre I., Mattei M.-G., Di Clemente N., Tizard R., Carre-Eusebe D., Belville C., Tragethon L., Tonkin C., Nelson J., McAuliffe M., Bidart J.-M., Lababidi A., Josso N., Cate R. L., Picard J.-Y., Insensitivity to anti-Müllerian hormone due to a mutation in the human anti-Müllerian hormone receptor. Nature Genetics 1995 11 4 382 388 2-s2.0-0028972867
10. Josso N., Di Clemente N., Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF- β family. Trends in Endocrinology and Metabolism 2003 14 2 91 97 2-s2.0-0037731743 10.1016/S1043-2760(03)00005-5 (Pubitemid 36733922)
11. Hagen C. P., Aksglaede L., Sørensen K., Main K. M., Boas M., Cleemann L., Holm K., Gravholt C. H., Andersson A.-M., Pedersen A. T., Petersen J. H., Linneberg A., Kjaergaard S., Juul A., Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients. The Journal of Clinical Endocrinology & Metabolism 2010 95 11 5003 5010 2-s2.0-78049492520 10.1210/jc.2010-0930
12. Aksglaede L., Sørensen K., Boas M., Mouritsen A., Hagen C. P., Jensen R. B., Petersen J. H., Linneberg A., Andersson A.-M., Main K. M., Skakkebæk N. E., Juul A., Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. The Journal of Clinical Endocrinology & Metabolism 2010 95 12 5357 5364 2-s2.0-78650045339 10.1210/jc.2010-1207
13. Hagen C. P., Aksglaede L., Sørensen K., Mouritsen A., Juul A., Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges. Pediatric Endocrinology Reviews 2011 9 525 528 2-s2.0-84859256632
14. Arango N. A., Lovell-Badge R., Behringer R. R., Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 1999 99 4 409 419 2-s2.0-0032705186
15. Swain A., Lovell-Badge R., Mammalian sex determination: a molecular drama. Genes and Development 1999 13 7 755 767 2-s2.0-0033118412 (Pubitemid 29169835)
16. Jørgensen A., Nielsen J. E., Jensen M. B., Graem N., Rajpert-de Meyts E., Analysis of meiosis regulators in human gonads: a sexually dimorphic spatio-temporal expression pattern suggests involvement of DMRT1 in meiotic entry. Molecular Human Reproduction 2012 18 523 534
17. Rey R., Lordereau-Richard I., Carel J.-C., Barbet P., Cate R. L., Roger M., Chaussain J.-L., Josso N., Anti-Müllerian hormone and testosterone serum levels are inversely related during normal and precocious pubertal development. The Journal of Clinical Endocrinology & Metabolism 1993 77 5 1220 1226 2-s2.0-0027696870 10.1210/jc.77.5.1220 (Pubitemid 23345473)
18. Lee M. M., Donahoe P. K., Hasegawa T., Silverman B., Crist G. B., Best S., Hasegawa Y., Noto R. A., Schoenfeld D., MacLaughlin D. T., Müllerian inhibiting substance in humans: normal levels from infancy to adulthood. The Journal of Clinical Endocrinology & Metabolism 1996 81 2 571 576 2-s2.0-9044238435 10.1210/jc.81.2.571 (Pubitemid 26055665)
19. Baker M. L., Hutson J. M., Serum levels of Müllerian inhibiting substance in boys throughout puberty and in the first two years of life. The Journal of Clinical Endocrinology & Metabolism 1993 76 1 245 247 2-s2.0-0027455734 10.1210/jc.76.1.245 (Pubitemid 23027587)
20. Steger K., Rey R., Kliesch S., Louis F., Schleicher G., Bergmann M., Immunohistochemical detection of immature Sertoli cell markers in testicular tissue of infertile adult men: a preliminary study. International Journal of Andrology 1996 19 2 122 128 2-s2.0-0029952181 (Pubitemid 26158693)
21. Rajpert-de Meyts E., Jørgensen N., Græm N., Müller J., Cate R. L., Skakkebæk N. E., Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. The Journal of Clinical Endocrinology & Metabolism 1999 84 10 3836 3844 2-s2.0-0033305357 (Pubitemid 30645250)
22. Grinspon R. P., Loreti N., Braslavsky D., Bedecarrás P., Ambao V., Gottlieb S., Bergadá I., Campo S. M., Rey R. A., Sertoli cell markers in the diagnosis of paediatric male hypogonadism. Journal of Pediatric Endocrinology and Metabolism 2012 25 1-2 3 11 2-s2.0-84858163280 10.1515/jpem-2011-0453
23. Grinspon R. P., Rey R. A., Anti-Müllerian hormone and sertoli cell function in paediatric male hypogonadism. Hormone Research in Paediatrics 2010 73 2 81 92 2-s2.0-77951294069 10.1159/000277140
24. Lukas-Croisier C., Lasala C., Nicaud J., Bedecarrás P., Kumar T. R., Dutertre M., Matzuk M. M., Picard J.-Y., Josso N., Rey R., Follicle-stimulating hormone increases testicular anti-Müllerian hormone (AMH) production through Sertoli cell proliferation and a nonclassical cyclic adenosine 5′-monophosphate-mediated activation of the AMH gene. Molecular Endocrinology 2003 17 4 550 561 2-s2.0-0242440967 10.1210/me.2002-0186 (Pubitemid 36403570)
25. Boukari K., Meduri G., Brailly-Tabard S., Guibourdenche J., Ciampi M. L., Massin N., Martinerie L., Picard J.-Y., Rey R., Lombès M., Young J., Lack of androgen receptor expression in sertoli cells accounts for the absence of anti-Müllerian hormone repression during early human testis development. The Journal of Clinical Endocrinology & Metabolism 2009 94 5 1818 1825 2-s2.0-66149090735 10.1210/jc.2008-1909
26. Jegou B., The Sertoli-germ cell communication network in mammals. International Review of Cytology 1993 147 25 96 2-s2.0-0027771127 (Pubitemid 24025725)
27. Rey R., Al-Attar L., Louis F., Jaubert F., Barbet P., Nihoul-Fékété C., Chaussan J.-L., Josso N., Testicular dysgenesis does not affect expression of anti-Müllerian hormone by sertoli cells in premeiotic seminiferous tubules. American Journal of Pathology 1996 148 5 1689 1698 2-s2.0-0029864920
28. Rey R., Endocrine, paracrine and cellular regulation of postnatal anti-Müllerian hormone secretion by Sertoli cells. Trends in Endocrinology and Metabolism 1998 9 7 271 276 2-s2.0-0032171285 10.1016/S1043-2760(98)00069-1 (Pubitemid 28394974)
29. Bezard J., Vigier B., Tran D., Mauleon P., Josso N., Anti-Müllerian hormone in sheep follicles. Reproduction Nutrition Developpement 1988 28 4 B 1105 1112 2-s2.0-0023822222
30. Weenen C., Laven J. S. E., von Bergh A. R. M., Cranfield M., Groome N. P., Visser J. A., Kramer P., Fauser B. C. J. M., Themmen A. P. N., Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Molecular Human Reproduction 2004 10 2 77 83 2-s2.0-1042268776 10.1093/molehr/gah015 (Pubitemid 38196508)
31. Jeppesen J. V., Anderson R. A., Kelsey T. W., Christiansen S. L., Kristensen S. G., Jayaprakasan K., Raine-Fenning N., Campbell B. K., Yding Andersen C., Which follicles make the most anti-Müllerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Molecular Human Reproduction 2013 19 8 519 527 10.1093/molehr/gat024
32. Hansen K. R., Hodnett G. M., Knowlton N., Craig L. B., Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertility and Sterility 2011 95 1 170 175 2-s2.0-78650039467 10.1016/j.fertnstert.2010.04.006
33. Hagen C. P., Aksglaede L., Sørensen K., Mouritsen A., Andersson A.-M., Petersen J. H., Main K. M., Juul A., Individual serum levels of anti-Mllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Human Reproduction 2012 27 3 861 866 2-s2.0-84857211282 10.1093/humrep/der435
34. Lashen H., Dunger D. B., Ness A., Ong K. K., Peripubertal changes in circulating anti-Müllerian hormone levels in girls. Fertility and Sterility 2013 99 7 2071 2075 10.1016/j.fertnstert.2013.01.139
35. Wallace W. H. B., Kelsey T. W., Human ovarian reserve from conception to the menopause. PloS ONE 2010 5 1 e8772 2-s2.0-77952508440 10.1371/journal.pone. 0008772
36. La Marca A., Broekmans F. J., Volpe A., Fauser B. C., MacKlon N. S., Anti-Müllerian hormone (AMH): what do we still need to know? Human Reproduction 2009 24 9 2264 2275 2-s2.0-68949211180 10.1093/humrep/dep210
37. Di Clemente N., Wilson C., Faure E., Boussin L., Carmillo P., Tizard R., Picard J.-Y., Vigier B., Josso N., Cate R., Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Molecular Endocrinology 1994 8 8 1006 1020 2-s2.0-0028106201 10.1210/me.8.8.1006 (Pubitemid 24254008)
38. Grossman M. P., Nakajima S. T., Fallat M. E., Siow Y., Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertility and Sterility 2008 89 5 1364 1370 2-s2.0-43549115464 10.1016/j.fertnstert.2007.03.066 (Pubitemid 351680087)
39. Nielsen M. E., Rasmussen I. A., Kristensen S. G., Christensen S. T., Møllgård K., Wreford Andersen E., Byskov A. G., Yding Andersen C., In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Molecular Human Reproduction 2011 17 1 63 70 2-s2.0-78650391249 10.1093/molehr/gaq073 gaq073
40. Nelson S. M., La Marca A., The journey from the old to the new AMH assay: how to avoid getting lost in the values. Reproductive BioMedicine Online 2011 23 4 411 420 2-s2.0-80053563342 10.1016/j.rbmo.2011.06.011
41. Kumar A., Kalra B., Patel A., McDavid L., Roudebush W. E., Development of a second generation anti-Müllerian hormone (AMH) ELISA. Journal of Immunological Methods 2010 362 1-2 51 59 2-s2.0-77958495101 10.1016/j.jim.2010. 08.011
42. Li H. W., Ng E. H., Wong B. P., Anderson R. A., Ho P. C., Yeung W. S., Correlation between three assay systems for anti-Müllerian hormone (AMH) determination. Journal of Assisted Reproduction and Genetics 2012 29 1443 1446
43. Lie F. S., Visser J. A., Welt C. K., de Rijke Y. B., Eijkemans M. J., Broekmans F. J., Roes E. M., Peters W. H., Hokken-Koelega A. C., Fauser B. C., Themmen A. P., de Jong F. H., Schipper I., Laven J. S., Serum anti-Müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. The Journal of Clinical Endocrinology & Metabolism 2012 97 4650 4655
44. Fleming R., Nelson S. M., Reproducibility of AMH. Human Reproduction 2012 27 3639 3641
45. Wallace A. M., Faye S. A., Fleming R., Nelson S. M., A multicentre evaluation of the new Beckman Coulter anti-Müllerian hormone immunoassay (AMH Gen II). Annals of Clinical Biochemistry 2011 48 4 370 373 2-s2.0-79960462335 10.1258/acb.2011.010172
46. Hehenkamp W. J. K., Looman C. W. N., Themmen A. P. N., De Jong F. H., Te Velde E. R., Broekmans F. J. M., Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. The Journal of Clinical Endocrinology & Metabolism 2006 91 10 4057 4063 2-s2.0-33749567109 10.1210/jc.2006-0331 (Pubitemid 44536885)
47. Kelsey T. W., Wright P., Nelson S. M., Anderson R. A., Wallace W. H. B., A validated model of serum Anti-Müllerian hormone from conception to menopause. PLoS ONE 2011 6 7 2-s2.0-79960293852 10.1371/journal.pone.0022024 e22024
48. Lee M. M., Donahoe P. K., Silverman B. L., Hasegawa T., Hasegawa Y., Gustafson M. L., Chang Y., MacLaughlin D. T., Measurements of serum Müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. The New England Journal of Medicine 1997 336 21 1480 1486 2-s2.0-0030611549 10.1056/NEJM199705223362102 (Pubitemid 27215162)
49. Stoppa-Vaucher S., Djemli A., Van Vliet G., Undetectable AMH at 3days of age: a clue to bilateral anorchia. Clinical Biochemistry 2010 43 16-17 1373 1374 2-s2.0-77957359103 10.1016/j.clinbiochem.2010.08.022
50. Misra M., MacLaughlin D. T., Donahoe P. K., Lee M. M., Massachusetts M., Measurement of Müllerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. The Journal of Clinical Endocrinology & Metabolism 2002 87 8 3598 3602 2-s2.0-0036342730 10.1210/jc.87.8.3598 (Pubitemid 34879501)
51. Grinspon R. P., Rey R. A., New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a sertoli cell marker. Arquivos Brasileiros de Endocrinologia e Metabologia 2011 55 8 512 519 2-s2.0-84855438747
52. Brauner R., Neve M., Allali S., Trivin C., Lottmann H., Bashamboo A., McElreavey K., Clinical, biological and genetic analysis of anorchia in 26 boys. PLoS ONE 2011 6 8 2-s2.0-80051530998 10.1371/journal.pone.0023292 e23292
53. Guibourdenche J., Lucidarme N., Chevenne D., Rigal O., Nicolas M., Luton D., Léger J., Porquet D., Noël M., Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Molecular and Cellular Endocrinology 2003 211 1-2 55 63 2-s2.0-0344515660 10.1016/j.mce.2003.09.011 (Pubitemid 37491236)
54. Gustafson M. L., Lee M. M., Asmundson L., MacLaughlin D. T., Donahoe P. K., Pena A., Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities. Journal of Pediatric Surgery 1993 28 3 439 444 2-s2.0-0027339710 10.1016/0022-3468(93)90245-G (Pubitemid 23091057)
55. Lee M. M., Misra M., Donahoe P. K., MacLaughlin D. T., MIS/AMH in the assessment of cryptorchidism and intersex conditions. Molecular and Cellular Endocrinology 2003 211 1-2 91 98 2-s2.0-0344084412 10.1016/j.mce.2003.09.014 (Pubitemid 37491240)
56. Pierik F. H., Deddens J. A., Burdorf A., Keizer-Schrama S. M. P. F. D. M., Jong F. H. D., Weber R. F. A., The hypothalamus-pituitary-testis axis in boys during the first six months of life: a comparison of cryptorchidism and hypospadias cases with controls. International Journal of Andrology 2009 32 5 453 461 2-s2.0-70049092550 10.1111/j.1365-2605.2008.00877.x
57. Josso N., Rey R., Picard J. Y., Testicular anti-Müllerian hormone: clinical applications in DSD. Seminars in Reproductive Medicine 2012 30 364 373
58. Belville C., Van Vlijmen H., Ehrenfels C., Pepinsky B., Rezaie A. R., Picard J.-Y., Josso N., Di Clemente N., Cate R. L., Mutations of the anti-Müllerian hormone gene in patients with persistent Müllerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Molecular Endocrinology 2004 18 3 708 721 2-s2.0-1542327546 10.1210/me.2003-0358 (Pubitemid 38328214)
59. Josso N., Belville C., di Clemente N., Picard J.-Y., AMH and AMH receptor defects in persistent Müllerian duct syndrome. Human Reproduction Update 2005 11 4 351 356 2-s2.0-21244498141 10.1093/humupd/dmi014 (Pubitemid 40895464)
60. Guerrier D., Tran D., Vanderwinden J. M., Hideux S., Van Outryve L., Legeai L., Bouchard M., Van Vliet G., De Laet M. H., Picard J. Y., Kahn A., Josso N., The persistent Müllerian duct syndrome: a molecular approach. The Journal of Clinical Endocrinology & Metabolism 1989 68 1 46 52 2-s2.0-0024476806 (Pubitemid 19028721)
61. Misra M., MacLaughlin D. T., Donahoe P. K., Lee M. M., The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization. The Journal of Clinical Endocrinology & Metabolism 2003 88 2 787 792 2-s2.0-0037328571 10.1210/jc.2002-020889 (Pubitemid 36207823)
62. Hagen C. P., Main K. M., Kjaergaard S., Juul A., FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous puberty. Human Reproduction 2010 25 12 3134 3141 2-s2.0-78649493846 10.1093/humrep/deq291
63. Visser J. A., Hokken-Koelega A. C., Zandwijken G. R., Limacher A., Ranke M. B., Fluck C. E., Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Human Reproduction 2013 28 7 1899 1907 10.1093/humrep/det089
64. Brougham M. F., Crofton P. M., Johnson E. J., Evans N., Anderson R. A., Wallace W. H., Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study. The Journal of Clinical Endocrinology & Metabolism 2012 97 2059 2067
65. Adan L., Lechevalier P., Couto-Silva A.-C., Boissan M., Trivin C., Brailly-Tabard S., Brauner R., Plasma inhibin B and anti-Müllerian hormone concentrations in boys: discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay. Case Reports and Clinical Practice Review 2010 16 11 CR511 CR517 2-s2.0-79951573220
66. Hero M., Tommiska J., Vaaralahti K., Laitinen E.-M., Sipilä I., Puhakka L., Dunkel L., Raivio T., Circulating anti-Müllerian hormone levels in boys decline during early puberty and correlate with inhibin B. Fertility and Sterility 2012 97 5 1242 1247 2-s2.0-84860322528 10.1016/j.fertnstert.2012. 02.020
67. Young J., Rey R., Schaison G., Chanson P., Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans. Molecular and Cellular Endocrinology 2003 211 1-2 51 54 2-s2.0-0344515657 10.1016/j.mce.2003.09.020 (Pubitemid 37491235)
68. Coutant R., Biette-Demeneix E., Bouvattier C., Bouhours-Nouet N., Gatelais F., Dufresne S., Rouleau S., Lahlou N., Baseline inhibin B and anti-Müllerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. The Journal of Clinical Endocrinology & Metabolism 2010 95 12 5225 5232 2-s2.0-78650048626 10.1210/jc.2010-1535
69. Hagen C. P., Sorensen K., Anderson R. A., Juul A., Serum levels of anti-Müllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist. Fertility and Sterility 2012 98 1326 1330
70. Sönmezer M., Özmen B., Atabekoglu C. S., Papuccu E. G., Ozkavukcu S., Berker B., Pabuccu R., Serum anti-Müllerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism. Journal of Assisted Reproduction and Genetics 2012 1 6 2-s2.0-84860545095 10.1007/s10815-012-9759-1
71. Aksglaede L., Christiansen P., Sørensen K., Boas M., Linneberg A., Main K. M., Andersson A.-M., Skakkebæk N. E., Juul A., Serum concentrations of Anti-Müllerian Hormone (AMH) in 95 patients with Klinefelter syndrome with or without cryptorchidism. Acta Paediatrica 2011 100 6 839 845 2-s2.0-79955522371 10.1111/j.1651-2227.2011.02148.x
72. Bastida M. G., Rey R. A., Bergadá I., Bedecarrás P., Andreone L., Del Rey G., Boywitt A., Ropelato M. G., Cassinelli H., Arcari A., Campo S., Gottlieb S., Establishment of testicular endocrine function impairment during childhood and puberty in boys with Klinefelter syndrome. Clinical Endocrinology 2007 67 6 863 870 2-s2.0-36249003310 10.1111/j.1365-2265.2007. 02977.x (Pubitemid 350135129)
73. Lahlou N., Fennoy I., Carel J.-C., Roger M., Inhibin B and anti-Müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic klinefelter syndrome. The Journal of Clinical Endocrinology & Metabolism 2004 89 4 1864 1868 2-s2.0-1942472654 10.1210/jc.2003-031624 (Pubitemid 38507946)
74. Pacenza N., Pasqualini T., Gottlieb S., Knoblovits P., Costanzo P. R., Stewart Usher J., Rey R. A., Martínez M. P., Aszpis S., Clinical presentation of Klinefelter's syndrome: differences according to age. International Journal of Endocrinology 2012 2012 6 2-s2.0-84856389510 10.1155/2012/324835 324835
75. Rey R. A., Gottlieb S., Pasqualini T., Bastida M. G., Grinspon R. P., Campo S. M., Bergadá I., Are Klinefelter boys hypogonadal? Acta Paediatrica 2011 100 6 830 838 2-s2.0-79955487415 10.1111/j.1651-2227.2010. 02137.x
76. Wikström A. M., Raivio T., Hadziselimovic F., Wikström S., Tuuri T., Dunkel L., Klinefelter syndrome in adolescence: onset of puberty is associated with accelerated germ cell depletion. The Journal of Clinical Endocrinology & Metabolism 2004 89 5 2263 2270 2-s2.0-2442471709 10.1210/jc.2003-031725 (Pubitemid 38619862)
77. Ali S., Gattuso P., Howard A., Mosunjac M. B., Siddiqui M. T., Adult granulosa cell tumor of the ovary: fine-needle-aspiration cytology of 10 cases and review of literature. Diagnostic Cytopathology 2008 36 5 297 302 2-s2.0-43049103465 10.1002/dc.20798 (Pubitemid 351631353)
78. Kanthan R., Senger J. L., Kanthan S., The multifaceted granulosa cell tumours-myths and realities: a review. ISRN Obstetrics and Gynecology 2012 2012 12 10.5402/2012/878635 878635
79. Colombo N., Parma G., Zanagnolo V., Insinga A., Management of ovarian stromal cell tumors. Journal of Clinical Oncology 2007 25 20 2944 2951 2-s2.0-34447526801 10.1200/JCO.2007.11.1005 (Pubitemid 47123159)
80. Schumer S. T., Cannistra S. A., Granulosa cell tumor of the ovary. Journal of Clinical Oncology 2003 21 6 1180 1189 2-s2.0-0037445186 10.1200/JCO.2003.10.019 (Pubitemid 46594151)
81. Ashnagar A., Alavi S., Nilipour Y., Azma R., Falahati F., Massive ascites as the only sign of ovarian juvenile granulosa cell tumor in an adolescent: a case report and a review of the literature. Case Reports in Oncological Medicine 2013 2013 4 10.1155/2013/386725 386725
82. La Marca A., Volpe A., The anti-Müllerian hormone and ovarian cancer. Human Reproduction Update 2007 13 3 265 273 2-s2.0-34347218225 10.1093/humupd/dml060 (Pubitemid 47061633)
83. Silverman L. A., Gitelman S. E., Immunoreactive inhibin, Müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors. Journal of Pediatrics 1996 129 6 918 921 2-s2.0-0030300021 (Pubitemid 27500374)
84. Gustafson M. L., Lee M. M., Scully R. E., Moncure A. C., Hirakawa T., Goodman A., Muntz H. G., Donahoe P. K., MacLaughlin D. T., Fuller A. F. Jr., Müllerian inhibiting substance as a marker for ovarian sex-cord tumor. The New England Journal of Medicine 1992 326 7 466 471 2-s2.0-0026609778
85. Rey R. A., Lhomme C., Marcillac I., Lahlou N., Duvillard P., Jesse N., Bidart J. M., Anti-Müllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum α -inhibin and estradiol. American Journal of Obstetrics and Gynecology 1996 174 3 958 965 2-s2.0-0029664887 10.1016/S0002-9378(96)70333-2 (Pubitemid 26114717)
86. Lane A. H., Lee M. M., Fuller A. F. Jr., Kehas D. J., Donahoe P. K., MacLaughlin D. T., Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors. Gynecologic Oncology 1999 73 1 51 55 2-s2.0-0032586769 10.1006/gyno.1998.5290 (Pubitemid 29177599)
87. Long W.-Q., Ranchin V., Pautier P., Belville C., Denizot P., Cailla H., Lhommé C., Picard J.-Y., Bidart J.-M., Rey R., Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. The Journal of Clinical Endocrinology & Metabolism 2000 85 2 540 544 2-s2.0-17744376762 10.1210/jc.85.2.540 (Pubitemid 32273631)
88. Chang H. L., Pahlavan N., Halpern E. F., MacLaughlin D. T., Serum Müllerian inhibiting substance/anti-Müllerian Hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology. Gynecologic Oncology 2009 114 1 57 60 2-s2.0-67349115264 10.1016/j.ygyno.2009.02.023
89. Puls L. E., Hamous J., Morrow M. S., Schneyer A., MacLaughlin D. T., Castracane V. D., Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience. Gynecologic Oncology 1994 54 3 396 401 2-s2.0-0028107946 10.1006/gyno.1994.1232 (Pubitemid 24301922)
90. Rey R., Sabourin J.-C., Venara M., Long W.-Q., Jaubert F., Zeller W. P., Duvillard P., Chemes H., Bidart J.-M., Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Human Pathology 2000 31 10 1202 1208 2-s2.0-0033623491 10.1053/hupa.2000.18498
91. Anttonen M., Unkila-Kallio L., Leminen A., Butzow R., Heikinheimo M., High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors. The Journal of Clinical Endocrinology & Metabolism 2005 90 12 6529 6535 2-s2.0-28744454443 10.1210/jc.2005-0921 (Pubitemid 41759309)
92. Sir-Petermann T., Codner E., Maliqueo M., Echiburú B., Hitschfeld C., Crisosto N., Pérez-Bravo F., Recabarren S. E., Cassorla F., Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 2006 91 8 3105 3109 2-s2.0-33747663528 10.1210/jc.2005-2693 (Pubitemid 44271764)
93. Pigny P., Merlen E., Robert Y., Cortet-Rudelli C., Decanter C., Jonard S., Dewailly D., Elevated serum level of anti-Müllerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. The Journal of Clinical Endocrinology & Metabolism 2003 88 12 5957 5962 2-s2.0-0242479340 10.1210/jc.2003-030727 (Pubitemid 38033078)
94. Laven J. S. E., Mulders A. G. M. G. J., Visser J. A., Themmen A. P., De Jong F. H., Fauser B. C. J. M., Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. The Journal of Clinical Endocrinology & Metabolism 2004 89 1 318 323 2-s2.0-0842312978 10.1210/jc.2003-030932 (Pubitemid 38183899)
95. Dewailly D., Gronier H., Poncelet E., Robin G., Leroy M., Pigny P., Duhamel A., Catteau-Jonard S., Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Human Reproduction 2011 26 11 3123 3129 2-s2.0-80054954059 10.1093/humrep/der297
96. Hart R., Doherty D. A., Norman R. J., Franks S., Dickinson J. E., Hickey M., Sloboda D. M., Serum anti-Müllerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertility and Sterility 2010 94 3 1118 1121 2-s2.0-77955568172 10.1016/j.fertnstert.2009.11.002
97. Li L., Chen X., Mo Y., Chen Y., Wenig M., Yang D., Elevated serum anti-Müllerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome. Wiener Klinische Wochenschrift 2010 122 17-18 519 524 2-s2.0-77957262508 10.1007/s00508-010-1426-x
98. Pigny P., Jonard S., Robert Y., Dewailly D., Serum anti-Müllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 2006 91 3 941 945 2-s2.0-33644823603 10.1210/jc.2005-2076 (Pubitemid 43357762)
99. Casadei L., Madrigale A., Puca F., Manicuti C., Emidi E., Piccione E., Dewailly D., The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome. Gynecological Endocrinology 2013 29 6 545 550 10.3109/09513590.2013.777415
100. Apter D., Viinikka L., Vihko R., Hormonal pattern of adolescent menstrual cycles. The Journal of Clinical Endocrinology & Metabolism 1978 47 5 944 954 2-s2.0-0018121835 (Pubitemid 9047377)
101. Rigon F., De Sanctis V., Bernasconi S., Bianchin L., Bona G., Bozzola M., Buzi F., Radetti G., Tato L., Tonini G., De Sanctis C., Perissinotto E., Menstrual pattern and menstrual disorders among adolescents: an update of the Italian data. Italian Journal of Pediatrics 2012 38 38 10.1186/1824-7288-38-38
102. Vollman R. F., The menstrual cycle. Major Problems in Obstetrics and Gynecology 1977 7 1 193 2-s2.0-0017438398
103. Pawelczak M., Kenigsberg L., Milla S., Liu Y. H., Shah B., Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features. Journal of Pediatric Endocrinology and Metabolism 2012 25 983 989
104. Park A. S., Lawson M. A., Chuan S. S., Oberfield S. E., Hoeger K. M., Witchel S. F., Chang R. J., Serum anti-Müllerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism. The Journal of Clinical Endocrinology & Metabolism 2010 95 4 1786 1792 2-s2.0-77951648127 10.1210/jc.2009-2106
105. Bentzen J. G., Forman J. L., Pinborg A., Lidegaard O., Larsen E. C., Friis-Hansen L., Johannsen T. H., Nyboe A. A., Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reproductive BioMedicine Online 2012 25 612 619
106. Arbo E., Vetori D. V., Jimenez M. F., Freitas F. M., Lemos N., Cunha-Filho J. S., Serum anti-Müllerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills. Human Reproduction 2007 22 12 3192 3196 2-s2.0-40449085482 10.1093/humrep/dem258 (Pubitemid 351696766)